-+ 0.00%
-+ 0.00%
-+ 0.00%

Novanta Q3 2026 net income drops 81% to USD 2.02 million

PUBT·11/09/2026 21:59:06
Listen to the news
Novanta Q3 2026 net income drops 81% to USD 2.02 million
  • Novanta's third-quarter 2026 net income fell 81% year-over-year to USD 2.02 million.
  • Revenue climbed 23% to USD 305.01 million.
  • Operating cash flow rose to USD 39.34 million.
  • The business closed its largest acquisition, Riverpoint Medical, which is performing in line with management's expectations.
  • Fourth-quarter 2026 revenue is forecast at USD 306 million to USD 312 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Novanta Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261109273457) on November 09, 2026, and is solely responsible for the information contained therein.